93 related articles for article (PubMed ID: 2574050)
1. Inhibition of gastric secretion following single morning or twice daily oral administration of sufotidine to volunteers.
Johnston DA; Wormsley KG
Br J Clin Pharmacol; 1989 Oct; 28(4):403-7. PubMed ID: 2574050
[TBL] [Abstract][Full Text] [Related]
2. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
3. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
Stables R; Humphray JM; Reeves JJ
Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
[TBL] [Abstract][Full Text] [Related]
4. Loss of acid suppression during dosing with H2-receptor antagonists.
Wilder-Smith C; Halter F; Ernst T; Gennoni M; Zeyen B; Varga L; Roehmel JJ; Merki HS
Aliment Pharmacol Ther; 1990; 4 Suppl 1():15-27. PubMed ID: 1983344
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human gastric secretion by ICI 162,846--a new histamine H2-receptor antagonist.
Wilson JA; Johnston DA; Penston J; Wormsley KG
Br J Clin Pharmacol; 1986 Jun; 21(6):685-9. PubMed ID: 2874823
[TBL] [Abstract][Full Text] [Related]
6. Intragastric acidity and serum gastrin after sufotidine.
Mela GS; Caputo E; Villa G; Savarino V; Zentilin P
Gut; 1990 Sep; 31(9):1087-8. PubMed ID: 1976577
[No Abstract] [Full Text] [Related]
7. Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
Smith JT; Pounder RE
Gut; 1990 Mar; 31(3):291-3. PubMed ID: 1969833
[TBL] [Abstract][Full Text] [Related]
8. Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482.
Wilder-Smith CH; Merki HS
Scand J Gastroenterol; 1991 May; 26(5):501-7. PubMed ID: 1678550
[TBL] [Abstract][Full Text] [Related]
9. Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
Smith JT; Gavey C; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():47-63. PubMed ID: 1983346
[TBL] [Abstract][Full Text] [Related]
10. Effects of loxtidine, a new histamine H2-receptor antagonist, on 24-hour gastric secretion in man.
Boyd EJ; Wormsley KG
Eur J Clin Pharmacol; 1984; 26(4):443-7. PubMed ID: 6145595
[TBL] [Abstract][Full Text] [Related]
11. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
[TBL] [Abstract][Full Text] [Related]
12. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
[TBL] [Abstract][Full Text] [Related]
13. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500
[TBL] [Abstract][Full Text] [Related]
14. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
[TBL] [Abstract][Full Text] [Related]
15. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Hammond JB; Offen WW
Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
[TBL] [Abstract][Full Text] [Related]
16. Do H2 receptor antagonists have to be given at night? A study of the antisecretory profile of SKF 94482, a new H2 receptor antagonist which has a profound effect on daytime acidity.
Chiverton SG; Burget DW; Hunt RH
Gut; 1989 May; 30(5):594-9. PubMed ID: 2567265
[TBL] [Abstract][Full Text] [Related]
17. Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.
Wichmann GC; Fölsch UR; von Kleist E; Hasse FM; Dillon M; Clowdus B; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):285-93. PubMed ID: 6147051
[TBL] [Abstract][Full Text] [Related]
18. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding.
Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779
[TBL] [Abstract][Full Text] [Related]
19. The pharmacodynamics and pharmacokinetics of multiple doses of the new H2-receptor antagonist, roxatidine acetate, in healthy men.
Lassman HB; Ho I; Puri SK; Sabo R; Scheffler MR
Drugs; 1988; 35 Suppl 3():53-64. PubMed ID: 2905250
[TBL] [Abstract][Full Text] [Related]
20. Effects of roxatidine acetate on 24-hour gastric acidity. Early evening versus bedtime administration in healthy subjects.
Hemery P; Congard P; Galmiche JP; Bonfils S
Drugs; 1988; 35 Suppl 3():76-81. PubMed ID: 2905253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
